B7-H4 overexpression in ovarian tumors

World Health Organization Classification of Tumours

2002 • 5,829 citations

Pathology and Genetics of Tumours of the Breast and Female Genital Organs

2003 • 2,779 citations

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

1996 • 2,766 citations

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

2003 • 1,938 citations

Blaustein's Pathology of the Female Genital Tract

2019 • 1,317 citations

Carcinoma of the Ovary

2006 • 1,284 citations

World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs

2005 • 834 citations

B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity

2003 • 665 citations

Blaustein's Pathology of the Female Genital Tract

2002 • 617 citations

Evaluation of Monoclonal Humanized Anti-HER2 Antibody, Trastuzumab, in Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Carcinoma With Overexpression of HER2: A Phase II Trial of the Gynecologic Oncology Group

2003 • 588 citations

Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

2004 • 442 citations

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

2002 • 421 citations

B7S1, a Novel B7 Family Member that Negatively Regulates T Cell Activation

2003 • 407 citations

Application of Mesothelin Immunostaining in Tumor Diagnosis

2003 • 367 citations

Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family

2003 • 238 citations

Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group.

1996 • 213 citations

B7-H4 Is Highly Expressed in Ductal and Lobular Breast Cancer

2005 • 210 citations

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation

2005 • 205 citations

Carcinoma of the ovary.

2001 • 198 citations

Blaustein's Pathology of the Female Genital Tract, 5th ed

2002 • 151 citations

Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate

2002 • 142 citations

Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.

2003 • 141 citations

Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses

2004 • 115 citations

Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors

1997 • 94 citations

BTLA: a new inhibitory receptor with a B7-like ligand

2003 • 89 citations

Update on the management of ovarian cancer.

2002 • 87 citations

Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital

1998 • 36 citations

Current Status of Taxane and Platinum-Based Chemotherapy in Ovarian Cancer

2003 • 34 citations

Clinically Apparent Early Stage Invasive Epithelial Ovarian Carcinoma: Should All Be Treated Similarly?

1999 • 22 citations

Survival of Patients with Epithelial Ovarian Cancer and the Effect of Lymphadenectomy in Those with Stage 3 Disease

1999 • 15 citations

S-100 protein in ovarian tumors. A comparative immunohistochemical study of 135 cases.

1991 • 14 citations

Surgical Management of Advanced Ovarian Cancer

2000 • 10 citations